On Friday, Biomarin Pharmaceutical Inc (NASDAQ: BMRN) opened lower -3.32% from the last session, before settling in for the closing price of $65.60. Price fluctuations for BMRN have ranged from $65.35 to $99.56 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 10.23%. Company’s average yearly earnings per share was noted 153.61% at the time writing. With a float of $188.17 million, this company’s outstanding shares have now reached $188.60 million.
Let’s determine the extent of company efficiency that accounts for 3401 employees. In terms of profitability, gross margin is 77.78%, operating margin of 11.45%, and the pretax margin is 14.3%.
Biomarin Pharmaceutical Inc (BMRN) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Biomarin Pharmaceutical Inc is 1.27%, while institutional ownership is 96.77%. The most recent insider transaction that took place on Nov 12 ’24, was worth 350,324. In this transaction EVP, Chief Technical Officer of this company sold 5,278 shares at a rate of $66.37, taking the stock ownership to the 68,909 shares. Before that another transaction happened on Nov 12 ’24, when Company’s Officer proposed sale 5,278 for $66.37, making the entire transaction worth $350,324.
Biomarin Pharmaceutical Inc (BMRN) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 153.61% per share during the next fiscal year.
Biomarin Pharmaceutical Inc (NASDAQ: BMRN) Trading Performance Indicators
Check out the current performance indicators for Biomarin Pharmaceutical Inc (BMRN). In the past quarter, the stock posted a quick ratio of 2.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.25. Likewise, its price to free cash flow for the trailing twelve months is 36.53.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.66, a number that is poised to hit 0.55 in the next quarter and is forecasted to reach 3.18 in one year’s time.
Technical Analysis of Biomarin Pharmaceutical Inc (BMRN)
Looking closely at Biomarin Pharmaceutical Inc (NASDAQ: BMRN), its last 5-days average volume was 1.32 million, which is a drop from its year-to-date volume of 1.83 million. As of the previous 9 days, the stock’s Stochastic %D was 19.54%. Additionally, its Average True Range was 1.51.
During the past 100 days, Biomarin Pharmaceutical Inc’s (BMRN) raw stochastic average was set at 0.63%, which indicates a significant decrease from 2.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 25.03% in the past 14 days, which was lower than the 39.79% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $70.43, while its 200-day Moving Average is $81.60. However, in the short run, Biomarin Pharmaceutical Inc’s stock first resistance to watch stands at $65.24. Second resistance stands at $67.06. The third major resistance level sits at $68.07. If the price goes on to break the first support level at $62.41, it is likely to go to the next support level at $61.40. Should the price break the second support level, the third support level stands at $59.58.
Biomarin Pharmaceutical Inc (NASDAQ: BMRN) Key Stats
There are currently 190,583K shares outstanding in the company with a market cap of 11.69 billion. Presently, the company’s annual sales total 2,419 M according to its annual income of 167,650 K. Last quarter, the company’s sales amounted to 745,740 K and its income totaled 106,080 K.
